Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adenosine and its receptors: multiple modulatory functions and potential therapeutic targets for neurologic disease.

× No keyword cloud information.

33 in total

1. High expression and activity of ecto-5'-nucleotidase/CD73 in the male murine reproductive tract.

Authors: Mireia Martín-Satué; Elise G Lavoie; Michel Fausther; Joanna Lecka; Elisabet Aliagas; Filip Kukulski; Jean Sévigny
Journal: Histochem Cell Biol Date: 2010-05-11 Impact factor: 4.304

2. Expression of equilibrative nucleoside transporter type 1 protein in elderly patients with schizophrenia.

Authors: Dan Shan; Vahram Haroutunian; James H Meador-Woodruff; Robert E McCullumsmith
Journal: Neuroreport Date: 2012-03-07 Impact factor: 1.837

3. A scaffold as a platform for new therapies?

Authors: Detlev Boison
Journal: Epilepsy Curr Date: 2012-09 Impact factor: 7.500

Review 4. Reducing safety-related drug attrition: the use of in vitro pharmacological profiling.

Authors: Joanne Bowes; Andrew J Brown; Jacques Hamon; Wolfgang Jarolimek; Arun Sridhar; Gareth Waldron; Steven Whitebread
Journal: Nat Rev Drug Discov Date: 2012-12 Impact factor: 84.694

5. Astrocytes derived from fetal neural progenitor cells as a novel source for therapeutic adenosine delivery.

Authors: Annelies Van Dycke; Robrecht Raedt; Alain Verstraete; Panos Theofilas; Wytse Wadman; Kristl Vonck; Detlev Boison; Paul Boon
Journal: Seizure Date: 2010-06-17 Impact factor: 3.184

Review 6. Adenosine dysfunction in epilepsy.

Authors: Detlev Boison
Journal: Glia Date: 2011-12-22 Impact factor: 7.452

Adenosine and its receptors: multiple modulatory functions and potential therapeutic targets for neurologic disease.

1. High expression and activity of ecto-5'-nucleotidase/CD73 in the male murine reproductive tract.

2. Expression of equilibrative nucleoside transporter type 1 protein in elderly patients with schizophrenia.

3. A scaffold as a platform for new therapies?

Review 4. Reducing safety-related drug attrition: the use of in vitro pharmacological profiling.

5. Astrocytes derived from fetal neural progenitor cells as a novel source for therapeutic adenosine delivery.

Review 6. Adenosine dysfunction in epilepsy.

Review 7. Mechanisms of sudden unexplained death in epilepsy.

8. Adenosine neuromodulation and traumatic brain injury.

Review 9. Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia.

10. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.